Maiden

In September last year, three cough syrups supplied by Maiden Pharmaceuticals were linked to the deaths of nearly 80 children in Gambia, but later the Indian government said that in-country examination had found no contamination in the drugs supplied to the African nation.

Gambia lawmakers say Maiden to blame for child kidney injury deaths

Maiden’s managing director, Naresh Kumar Goyal, did not immediately respond to calls and messages from Reuters on Tuesday.

Cough syrup that 'kills': Ground report from the Maiden Pharmaceuticals factory | WHO alert

4 cough syrups which are products of an Indian company called Maiden Pharmaceuticals could be responsible for the deaths of 66 children in Gambia, is what the WHO is saying. The world health body has said that a further probe is underway, along with Indian regulatory authorities. Moneycontrol visited the factory of Maiden pharmaceuticals in Haryana where sources tell us that drug control officials have been probing for the last 2days. Also, this is NOT the first time that this company has been in the midst of a controversy. Watch this ground report

US-based investment firm AWE launches Rs 350 crore maiden fund targeting India

With the development, AWE has joined the list of funds like Sequoia India, Elevation Capital, and Accel India which have launched new funds focusing on investment in India.

Apple makes renewable energy push with solar, fuel cells

Apple Inc now runs its largest US data centre entirely on renewable energy, with a majority of the power generated on-site from solar panels and fuel cells, the company's chief financial officer, Peter Oppenheimer, said.